Evidence map›Paper›PMID 28190714›Full record

ArticleJournal of vascular surgery2017

Carotid endarterectomy should not be based on consensus statement duplex velocity criteria.

Jesse A Columbo, Bjoern D Suckow, Claire L Griffin, Jack L Cronenwett, Philip P Goodney, Timothy G Lukovits, Robert M Zwolak, Mark F Fillinger

Open access · bronzeAbstract read
In one paragraph

Article in Journal of vascular surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Duplex velocity criteria for carotid endarterectomy.Journal of vascular surgery · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jesse A ColumboSection of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Bjoern D SuckowSection of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Claire L GriffinDepartment of Vascular Surgery, University of Utah, Salt Lake City, Utah.
Jack L CronenwettSection of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Philip P GoodneySection of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Timothy G LukovitsDepartment of Neurology, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Robert M ZwolakSection of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Mark F FillingerSection of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH. Electronic address: mark.f.fillinger@hitchcock.org.
Dartmouth–Hitchcock Medical Center · USUniversity of Utah · US

Funding

Creating National Surveillance Infrastructure for Priority Medical DevicesU01FD005478 · FDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI SEDRAKYAN, ART · 2015 to 2019
$6.5M
FDA HHS U01 FD005478
6 · The paper itself

Abstract

objectiveRandomized trials support carotid endarterectomy (CEA) in asymptomatic patients with ≥60% internal carotid artery (ICA) stenosis. The widely referenced Society for Radiologists in Ultrasound Consensus Statement on carotid duplex ultrasound (CDUS) imaging indicates that an ICA peak systolic velocity (PSV) ≥230 cm/s corresponds to a ≥70% ICA stenosis, leading to the potential conclusion that asymptomatic patients with an ICA PSV ≥230 cm/s would benefit from CEA. Our goal was to determine the natural history stroke risk of asymptomatic patients who might have undergone CEA based on consensus statement PSV of ≥230 cm/s but instead were treated medically based on more conservative CDUS imaging criteria.

methodsAll patients who underwent CDUS imaging at our institution during 2009 were retrospectively reviewed. The year 2009 was chosen to ensure extended follow-up. Asymptomatic patients were included if their ICA PSV was ≥230 cm/s but less than what our laboratory considers a ≥80% stenosis by CDUS imaging (PSV ≥430 cm/s, end-diastolic velocity ≥151 cm/s, or ICA/common carotid artery PSV ratio ≥7.5). Study end points included freedom from transient ischemic attack (TIA), freedom from any stroke, freedom from carotid-etiology stroke, and freedom from revascularization.

resultsCriteria for review were met by 327 patients. Mean follow-up was 4.3 years, with 85% of patients having >3-year follow-up. Four unheralded strokes occurred during follow-up at <1, 17, 25, and 30 months that were potentially attributable to the index carotid artery. Ipsilateral TIA occurred in 17 patients. An additional 12 strokes occurred that appeared unrelated to ipsilateral carotid disease, including hemorrhagic events, contralateral, and cerebellar strokes. Revascularization was undertaken in 59 patients, 1 for stroke, 12 for TIA, and 46 for asymptomatic disease. Actuarial freedom from carotid-etiology stroke was 99.7%, 98.4%, and 98.4% at 1, 3, and 5 years, respectively. Freedom from TIA was 98%, 96%, and 95%, freedom from any stroke was 99%, 96%, and 93%, and freedom from revascularization was 95%, 86%, and 81% at 1, 3, and 5 years, respectively.

conclusionsPatients with intermediate asymptomatic carotid stenosis (ICA PSV 230-429 cm/s) do well with medical therapy when carefully monitored and intervened upon using conservative CDUS criteria. Furthermore, a substantial number of patients would undergo unnecessary CEA if consensus statement CDUS thresholds are used to recommend surgery. Current velocity threshold recommendations should be re-evaluated, with potentially important implications for upcoming clinical trials.

Indexed as

Patient SelectionAgedAged, 80 and overAsymptomatic DiseasesBlood Flow VelocityCarotid Artery, InternalCarotid StenosisConsensusDisease-Free SurvivalEndarterectomy, CarotidFemaleHumansIschemic Attack, TransientKaplan-Meier EstimateMaleMiddle Aged

Identifiers

PMID28190714
PMCPMC5960978
OpenAlexW2397973515

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.